Researchers are looking at cancer drugs that could be taken at a lower dose, so long as they’re taken with food.
The cost of certain cancer drugs has gotten high, often to more than $100,000 a year.
To combat that, researchers are looking for treatments that could be taken at a lower dose, so long as they’re taken with food.
But finding the funding to study lower doses hasn’t been easy.
Dr. Mark Ratain, the chief hospital pharmacologist at the University of Chicago Medical Center, has spent the past decade thinking about a different kind of “drug target.”
Typically, the phrase is used to refer to the part of the body that an experimental drug is trying to modify.
Tech: A group of cancer doctors discovered a way to slash the cost expensive pills by up to 75%, but they’ve hit a wall
